Review



anti batf rabbit mab d7c5 cell signaling technology  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc anti batf rabbit mab d7c5 cell signaling technology
    Anti Batf Rabbit Mab D7c5 Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti batf rabbit mab d7c5 cell signaling technology/product/Cell Signaling Technology Inc
    Average 94 stars, based on 10 article reviews
    anti batf rabbit mab d7c5 cell signaling technology - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    Cell Signaling Technology Inc anti batf rabbit mab d7c5 cell signaling technology
    Anti Batf Rabbit Mab D7c5 Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti batf rabbit mab d7c5 cell signaling technology/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    anti batf rabbit mab d7c5 cell signaling technology - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc d7c5 cell signaling technology
    D7c5 Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d7c5 cell signaling technology/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    d7c5 cell signaling technology - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc batf clone d7c5 rabbit antibody
    Batf Clone D7c5 Rabbit Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/batf clone d7c5 rabbit antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    batf clone d7c5 rabbit antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc antibody against batf clone: d7c5
    ( A ) Visualization of integrated RNA-Seq and ChIP-Seq data from FACS-sorted murine BM-derived Flt3L-cultured WT pDCs using Cytoscape. Gene shape represents gene groups (filled circles = IFN I, triangles = ISGs, Squares = IRFs), colour of the gene shape indicates expression (red: high expression, yellow: moderate expression, green: low expression, grey: no expression), and colour of the arrow shows interaction (blue) or no interaction (grey) with <t>BATF</t> according to ChIP-Seq data. ( B ) Integrated RNA-Seq, ChIP-Seq and ATAC-Seq data for all mouse transcription factors in untreated (left) and 2h CpG stimulated (right) FACS-sorted murine BM-derived Flt3L-cultured pDCs visualized in Venn diagrams. Total number of genes among all mouse transcription factors is shown for expression of genes between WT and Batf -/- pDCs (RNA-Seq, fold change ≥ |1.5| and FDR ≤ 0.05, EdgeR), direct BATF interaction <t>with</t> <t>DNA</t> (ChIP-Seq peaks called after MACS) in WT pDCs and a differentially opening of chromatin between WT and Batf -/- pDCs (ATAC-Seq, fold change ≥ |1.5| and FDR ≤ 0.05, DESEq2). Genes matching all three criteria are listed to the right of the Venn diagrams. ( C ) Quantitative RT-PCR (left) for the expression of Zfp366 in FACS-purified untreated and CpG-stimulated WT ( Batf +/+ ) and Batf -/- pDCs. Heatmap (right) showing the normalized counts per million (cpm) expression of Zfp366 in Batf +/+ and Batf -/- pDCs at steady state (untreated) and after CpG stimulation (2h, 6h, 12h) from RNA-Seq data. ( D ) Quantitative RT-PCR for the relative expression of Zfp366 mRNA in Ifnar -/- and WT ( Ifnar +/+ ) purified BM-derived pDCs, which were left untreated or stimulated with CpG or IFNα2 for 6h. ( E ) Histograms (upper panel) and bar chart (lower) showing the Zfp366-tdTomato expression as MFI in untreated (-) and for 24h CpG-stimulated (CpG 1668/CpG 2216) BM-pDCs from DC-SCRIPT-reporter or WT (control; grey bar) mice. ( F ) Top panel presents a screen shot from the ECR (evolutionary conserved regions) Browser web site of 5’ region of the mouse Zfp366 gene. Intronic regions are depicted in pink, UTRs in yellow and conserved non-coding sequence (CNS) in red. Bottom panels present BATF ChIP-Seq (green) in sorted Batf +/+ , untreated and CpG stimulated (2h) pDCs, as well as ATAC-Seq (red) peaks in Batf +/+ and Batf -/- , untreated and CpG stimulated (2h) pDCs for the Zfp366 gene visualized with Integrative Genomics Viewer (IGV). ( G ) Alignment of the BATF binding position at - 3464 of the transcription start site (TSS) of the Zfp366 gene in different mammalian species. Alignment of the indicated genomic regions was performed with Jalview with the blue colouring representing percentage identity. The position of the BATF binding to the AP-1 motif is marked with a red box. ( H ) qRT-PCR presenting time course of Batf and Zfp366 expression in FACS-sorted BM-derived Flt3L-cultured pDCs from C57BL/6 mice. Data represents relative expression of Zfp366 (blue line) and Batf (red line) mRNA in resting (0) or CpG stimulated pDCs. ( I ) Quantitative RT-PCR showing the expression of Zfp366 in untreated and 16h CpG-stimulated, GFP or Batf -GFP-overexpressing purified Hoxb8-Fl pDCs. Data shown are from one representative experiment performed in triplicate (A & B RNA-Seq, C, D & H) or duplicate (Chip-Seq & ATAC-Seq A, B & F) out of three independent experiments with comparable results (C, D & H) or are combined data from three independent experiments (E & I). Data shown in A are log 2 fold change expression, in C, D, H, and I are the mean expression ± SEM from 3 to 4 biological replicates (normalized to Actb in C left, D, H, and I). Statistical differences between the groups were analyzed by unpaired two tailed t test (C & E & I), multiple t-test using Bonferroni correction (D), or two-way ANOVA followed by multiple comparisons using Bonferroni corrections (H). *: p < 0.05, **: p < 0.002, ***: p < 0.001
    Antibody Against Batf Clone: D7c5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody against batf clone: d7c5/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    antibody against batf clone: d7c5 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc alexa fluor 647-batf clone d7c5 antibody
    ( A ) Dot blots showing expression of <t>BATF</t> in splenic pDCs (CD3ε - , CD19 - , CD317 <t>high</t> <t>CD11c</t> intermediate and CCR9 + ) from C57BL/6 mice at steady state or after in vivo injection of CpG B (1668) complexed to dotap for the indicated time span. ( B ) Dot blots showing expression of BATF in murine BM-derived Flt3L-cultured pDCs at steady state (0h) or after in vitro stimulation of CpG A for the indicated amounts of time. ( C ) Dotblots (upper panel), histogram (lower left) and bar charts (lower right) showing expression of BATF in BM-derived Flt3L-cultured pDCs at steady state (0h) or after in vitro stimulation with CpG B for the indicated amounts of time. Vertical grey line indicates the BATF-median fluorescence intensity (MFI) in resting pDCs. ( D ) Quantitative RT-PCR for the relative expression of Ifnb1 (left) and Isg15 (right) mRNA, in BM-derived Flt3L-cultured, FACS purified pDCs from Ifnar -/- and wild-type ( Ifnar +/+ ) mice. Relative gene expression (mRNA) was analyzed at steady state (untreated) or after 6h stimulation with 1μM CpG or 100 units/ml IFNα4. Data shown are means ± SEM (normalized to Actb ). Data presented in A & B are from one representative sample from the data shown in & B respectively. Data shown are from one representative experiment out of three independent experiments with comparable results. Statistical differences were analyzed using two tailed t test (C) or two-way ANOVA followed by multiple comparisons test using Bonferroni correction (D). Gates were applied in B and C using FMO controls.
    Alexa Fluor 647 Batf Clone D7c5 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alexa fluor 647-batf clone d7c5 antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    alexa fluor 647-batf clone d7c5 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc batf d7c5 antibody
    ( A ) Dot blots showing expression of <t>BATF</t> in splenic pDCs (CD3ε - , CD19 - , CD317 <t>high</t> <t>CD11c</t> intermediate and CCR9 + ) from C57BL/6 mice at steady state or after in vivo injection of CpG B (1668) complexed to dotap for the indicated time span. ( B ) Dot blots showing expression of BATF in murine BM-derived Flt3L-cultured pDCs at steady state (0h) or after in vitro stimulation of CpG A for the indicated amounts of time. ( C ) Dotblots (upper panel), histogram (lower left) and bar charts (lower right) showing expression of BATF in BM-derived Flt3L-cultured pDCs at steady state (0h) or after in vitro stimulation with CpG B for the indicated amounts of time. Vertical grey line indicates the BATF-median fluorescence intensity (MFI) in resting pDCs. ( D ) Quantitative RT-PCR for the relative expression of Ifnb1 (left) and Isg15 (right) mRNA, in BM-derived Flt3L-cultured, FACS purified pDCs from Ifnar -/- and wild-type ( Ifnar +/+ ) mice. Relative gene expression (mRNA) was analyzed at steady state (untreated) or after 6h stimulation with 1μM CpG or 100 units/ml IFNα4. Data shown are means ± SEM (normalized to Actb ). Data presented in A & B are from one representative sample from the data shown in & B respectively. Data shown are from one representative experiment out of three independent experiments with comparable results. Statistical differences were analyzed using two tailed t test (C) or two-way ANOVA followed by multiple comparisons test using Bonferroni correction (D). Gates were applied in B and C using FMO controls.
    Batf D7c5 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/batf d7c5 antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    batf d7c5 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc c57bl 6 j antibody batf d7c5
    ( A ) Dot blots showing expression of <t>BATF</t> in splenic pDCs (CD3ε - , CD19 - , CD317 <t>high</t> <t>CD11c</t> intermediate and CCR9 + ) from C57BL/6 mice at steady state or after in vivo injection of CpG B (1668) complexed to dotap for the indicated time span. ( B ) Dot blots showing expression of BATF in murine BM-derived Flt3L-cultured pDCs at steady state (0h) or after in vitro stimulation of CpG A for the indicated amounts of time. ( C ) Dotblots (upper panel), histogram (lower left) and bar charts (lower right) showing expression of BATF in BM-derived Flt3L-cultured pDCs at steady state (0h) or after in vitro stimulation with CpG B for the indicated amounts of time. Vertical grey line indicates the BATF-median fluorescence intensity (MFI) in resting pDCs. ( D ) Quantitative RT-PCR for the relative expression of Ifnb1 (left) and Isg15 (right) mRNA, in BM-derived Flt3L-cultured, FACS purified pDCs from Ifnar -/- and wild-type ( Ifnar +/+ ) mice. Relative gene expression (mRNA) was analyzed at steady state (untreated) or after 6h stimulation with 1μM CpG or 100 units/ml IFNα4. Data shown are means ± SEM (normalized to Actb ). Data presented in A & B are from one representative sample from the data shown in & B respectively. Data shown are from one representative experiment out of three independent experiments with comparable results. Statistical differences were analyzed using two tailed t test (C) or two-way ANOVA followed by multiple comparisons test using Bonferroni correction (D). Gates were applied in B and C using FMO controls.
    C57bl 6 J Antibody Batf D7c5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c57bl 6 j antibody batf d7c5/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    c57bl 6 j antibody batf d7c5 - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc batf d7c5
    ( A ) The mice and liver Oil red O staining in normal diet group (CN) and high-fat diet group (HFD). Bar, 1 cm (left panel) and 100 μm (right panel). ( B ) The protein expression of <t>BATF</t> in liver tissues (n=4). ( C ) The mRNA expression of BATF in liver tissues (n=5). ( D ) Spearman correlation Analysis between TPM of BATF and NAFLD Patients with Different Degrees (n=4–18). ( E ) Triglyceride content (n=5). ( F ) Detection of BATF overexpression in HepG2 (n=2). ( G ) Oil red O staining of HepG2 cells with OA/PA when BATF was overexpressed and ( H ) triglyceride content (n=4). ( I ) Oil red O staining of L02 cells with OA/PA when BATF was overexpressed and ( J ) triglyceride content (n=3). ( K ) Oil red O staining of primary hepatocytes with OA/PA when BATF was overexpressed and ( L ) triglyceride content (n=3). The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 1—source data 1. Effects of BATF on lipid deposition in hepatocytes under high-fat diet.
    Batf D7c5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/batf d7c5/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    batf d7c5 - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc batf (d7c5; cell signaling technology)
    ( A ) The mice and liver Oil red O staining in normal diet group (CN) and high-fat diet group (HFD). Bar, 1 cm (left panel) and 100 μm (right panel). ( B ) The protein expression of <t>BATF</t> in liver tissues (n=4). ( C ) The mRNA expression of BATF in liver tissues (n=5). ( D ) Spearman correlation Analysis between TPM of BATF and NAFLD Patients with Different Degrees (n=4–18). ( E ) Triglyceride content (n=5). ( F ) Detection of BATF overexpression in HepG2 (n=2). ( G ) Oil red O staining of HepG2 cells with OA/PA when BATF was overexpressed and ( H ) triglyceride content (n=4). ( I ) Oil red O staining of L02 cells with OA/PA when BATF was overexpressed and ( J ) triglyceride content (n=3). ( K ) Oil red O staining of primary hepatocytes with OA/PA when BATF was overexpressed and ( L ) triglyceride content (n=3). The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 1—source data 1. Effects of BATF on lipid deposition in hepatocytes under high-fat diet.
    Batf (D7c5; Cell Signaling Technology), supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/batf (d7c5; cell signaling technology)/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    batf (d7c5; cell signaling technology) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc anti-batf clone d7c5

    Anti Batf Clone D7c5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-batf clone d7c5/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-batf clone d7c5 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Visualization of integrated RNA-Seq and ChIP-Seq data from FACS-sorted murine BM-derived Flt3L-cultured WT pDCs using Cytoscape. Gene shape represents gene groups (filled circles = IFN I, triangles = ISGs, Squares = IRFs), colour of the gene shape indicates expression (red: high expression, yellow: moderate expression, green: low expression, grey: no expression), and colour of the arrow shows interaction (blue) or no interaction (grey) with BATF according to ChIP-Seq data. ( B ) Integrated RNA-Seq, ChIP-Seq and ATAC-Seq data for all mouse transcription factors in untreated (left) and 2h CpG stimulated (right) FACS-sorted murine BM-derived Flt3L-cultured pDCs visualized in Venn diagrams. Total number of genes among all mouse transcription factors is shown for expression of genes between WT and Batf -/- pDCs (RNA-Seq, fold change ≥ |1.5| and FDR ≤ 0.05, EdgeR), direct BATF interaction with DNA (ChIP-Seq peaks called after MACS) in WT pDCs and a differentially opening of chromatin between WT and Batf -/- pDCs (ATAC-Seq, fold change ≥ |1.5| and FDR ≤ 0.05, DESEq2). Genes matching all three criteria are listed to the right of the Venn diagrams. ( C ) Quantitative RT-PCR (left) for the expression of Zfp366 in FACS-purified untreated and CpG-stimulated WT ( Batf +/+ ) and Batf -/- pDCs. Heatmap (right) showing the normalized counts per million (cpm) expression of Zfp366 in Batf +/+ and Batf -/- pDCs at steady state (untreated) and after CpG stimulation (2h, 6h, 12h) from RNA-Seq data. ( D ) Quantitative RT-PCR for the relative expression of Zfp366 mRNA in Ifnar -/- and WT ( Ifnar +/+ ) purified BM-derived pDCs, which were left untreated or stimulated with CpG or IFNα2 for 6h. ( E ) Histograms (upper panel) and bar chart (lower) showing the Zfp366-tdTomato expression as MFI in untreated (-) and for 24h CpG-stimulated (CpG 1668/CpG 2216) BM-pDCs from DC-SCRIPT-reporter or WT (control; grey bar) mice. ( F ) Top panel presents a screen shot from the ECR (evolutionary conserved regions) Browser web site of 5’ region of the mouse Zfp366 gene. Intronic regions are depicted in pink, UTRs in yellow and conserved non-coding sequence (CNS) in red. Bottom panels present BATF ChIP-Seq (green) in sorted Batf +/+ , untreated and CpG stimulated (2h) pDCs, as well as ATAC-Seq (red) peaks in Batf +/+ and Batf -/- , untreated and CpG stimulated (2h) pDCs for the Zfp366 gene visualized with Integrative Genomics Viewer (IGV). ( G ) Alignment of the BATF binding position at - 3464 of the transcription start site (TSS) of the Zfp366 gene in different mammalian species. Alignment of the indicated genomic regions was performed with Jalview with the blue colouring representing percentage identity. The position of the BATF binding to the AP-1 motif is marked with a red box. ( H ) qRT-PCR presenting time course of Batf and Zfp366 expression in FACS-sorted BM-derived Flt3L-cultured pDCs from C57BL/6 mice. Data represents relative expression of Zfp366 (blue line) and Batf (red line) mRNA in resting (0) or CpG stimulated pDCs. ( I ) Quantitative RT-PCR showing the expression of Zfp366 in untreated and 16h CpG-stimulated, GFP or Batf -GFP-overexpressing purified Hoxb8-Fl pDCs. Data shown are from one representative experiment performed in triplicate (A & B RNA-Seq, C, D & H) or duplicate (Chip-Seq & ATAC-Seq A, B & F) out of three independent experiments with comparable results (C, D & H) or are combined data from three independent experiments (E & I). Data shown in A are log 2 fold change expression, in C, D, H, and I are the mean expression ± SEM from 3 to 4 biological replicates (normalized to Actb in C left, D, H, and I). Statistical differences between the groups were analyzed by unpaired two tailed t test (C & E & I), multiple t-test using Bonferroni correction (D), or two-way ANOVA followed by multiple comparisons using Bonferroni corrections (H). *: p < 0.05, **: p < 0.002, ***: p < 0.001

    Journal: bioRxiv

    Article Title: BATF controls IFN I production via DC-SCRIPT in plasmacytoid dendritic cells

    doi: 10.1101/2024.01.11.574638

    Figure Lengend Snippet: ( A ) Visualization of integrated RNA-Seq and ChIP-Seq data from FACS-sorted murine BM-derived Flt3L-cultured WT pDCs using Cytoscape. Gene shape represents gene groups (filled circles = IFN I, triangles = ISGs, Squares = IRFs), colour of the gene shape indicates expression (red: high expression, yellow: moderate expression, green: low expression, grey: no expression), and colour of the arrow shows interaction (blue) or no interaction (grey) with BATF according to ChIP-Seq data. ( B ) Integrated RNA-Seq, ChIP-Seq and ATAC-Seq data for all mouse transcription factors in untreated (left) and 2h CpG stimulated (right) FACS-sorted murine BM-derived Flt3L-cultured pDCs visualized in Venn diagrams. Total number of genes among all mouse transcription factors is shown for expression of genes between WT and Batf -/- pDCs (RNA-Seq, fold change ≥ |1.5| and FDR ≤ 0.05, EdgeR), direct BATF interaction with DNA (ChIP-Seq peaks called after MACS) in WT pDCs and a differentially opening of chromatin between WT and Batf -/- pDCs (ATAC-Seq, fold change ≥ |1.5| and FDR ≤ 0.05, DESEq2). Genes matching all three criteria are listed to the right of the Venn diagrams. ( C ) Quantitative RT-PCR (left) for the expression of Zfp366 in FACS-purified untreated and CpG-stimulated WT ( Batf +/+ ) and Batf -/- pDCs. Heatmap (right) showing the normalized counts per million (cpm) expression of Zfp366 in Batf +/+ and Batf -/- pDCs at steady state (untreated) and after CpG stimulation (2h, 6h, 12h) from RNA-Seq data. ( D ) Quantitative RT-PCR for the relative expression of Zfp366 mRNA in Ifnar -/- and WT ( Ifnar +/+ ) purified BM-derived pDCs, which were left untreated or stimulated with CpG or IFNα2 for 6h. ( E ) Histograms (upper panel) and bar chart (lower) showing the Zfp366-tdTomato expression as MFI in untreated (-) and for 24h CpG-stimulated (CpG 1668/CpG 2216) BM-pDCs from DC-SCRIPT-reporter or WT (control; grey bar) mice. ( F ) Top panel presents a screen shot from the ECR (evolutionary conserved regions) Browser web site of 5’ region of the mouse Zfp366 gene. Intronic regions are depicted in pink, UTRs in yellow and conserved non-coding sequence (CNS) in red. Bottom panels present BATF ChIP-Seq (green) in sorted Batf +/+ , untreated and CpG stimulated (2h) pDCs, as well as ATAC-Seq (red) peaks in Batf +/+ and Batf -/- , untreated and CpG stimulated (2h) pDCs for the Zfp366 gene visualized with Integrative Genomics Viewer (IGV). ( G ) Alignment of the BATF binding position at - 3464 of the transcription start site (TSS) of the Zfp366 gene in different mammalian species. Alignment of the indicated genomic regions was performed with Jalview with the blue colouring representing percentage identity. The position of the BATF binding to the AP-1 motif is marked with a red box. ( H ) qRT-PCR presenting time course of Batf and Zfp366 expression in FACS-sorted BM-derived Flt3L-cultured pDCs from C57BL/6 mice. Data represents relative expression of Zfp366 (blue line) and Batf (red line) mRNA in resting (0) or CpG stimulated pDCs. ( I ) Quantitative RT-PCR showing the expression of Zfp366 in untreated and 16h CpG-stimulated, GFP or Batf -GFP-overexpressing purified Hoxb8-Fl pDCs. Data shown are from one representative experiment performed in triplicate (A & B RNA-Seq, C, D & H) or duplicate (Chip-Seq & ATAC-Seq A, B & F) out of three independent experiments with comparable results (C, D & H) or are combined data from three independent experiments (E & I). Data shown in A are log 2 fold change expression, in C, D, H, and I are the mean expression ± SEM from 3 to 4 biological replicates (normalized to Actb in C left, D, H, and I). Statistical differences between the groups were analyzed by unpaired two tailed t test (C & E & I), multiple t-test using Bonferroni correction (D), or two-way ANOVA followed by multiple comparisons using Bonferroni corrections (H). *: p < 0.05, **: p < 0.002, ***: p < 0.001

    Article Snippet: Genomic DNA regions of interest were isolated using 4μg of antibody against BATF (Clone: D7C5, Cell Signaling Technology, 8638BF).

    Techniques: RNA Sequencing, ChIP-sequencing, Derivative Assay, Cell Culture, Expressing, Quantitative RT-PCR, Purification, Control, Sequencing, Binding Assay, Two Tailed Test

    ( A ) Dot blots showing expression of BATF in splenic pDCs (CD3ε - , CD19 - , CD317 high CD11c intermediate and CCR9 + ) from C57BL/6 mice at steady state or after in vivo injection of CpG B (1668) complexed to dotap for the indicated time span. ( B ) Dot blots showing expression of BATF in murine BM-derived Flt3L-cultured pDCs at steady state (0h) or after in vitro stimulation of CpG A for the indicated amounts of time. ( C ) Dotblots (upper panel), histogram (lower left) and bar charts (lower right) showing expression of BATF in BM-derived Flt3L-cultured pDCs at steady state (0h) or after in vitro stimulation with CpG B for the indicated amounts of time. Vertical grey line indicates the BATF-median fluorescence intensity (MFI) in resting pDCs. ( D ) Quantitative RT-PCR for the relative expression of Ifnb1 (left) and Isg15 (right) mRNA, in BM-derived Flt3L-cultured, FACS purified pDCs from Ifnar -/- and wild-type ( Ifnar +/+ ) mice. Relative gene expression (mRNA) was analyzed at steady state (untreated) or after 6h stimulation with 1μM CpG or 100 units/ml IFNα4. Data shown are means ± SEM (normalized to Actb ). Data presented in A & B are from one representative sample from the data shown in & B respectively. Data shown are from one representative experiment out of three independent experiments with comparable results. Statistical differences were analyzed using two tailed t test (C) or two-way ANOVA followed by multiple comparisons test using Bonferroni correction (D). Gates were applied in B and C using FMO controls.

    Journal: bioRxiv

    Article Title: BATF controls IFN I production via DC-SCRIPT in plasmacytoid dendritic cells

    doi: 10.1101/2024.01.11.574638

    Figure Lengend Snippet: ( A ) Dot blots showing expression of BATF in splenic pDCs (CD3ε - , CD19 - , CD317 high CD11c intermediate and CCR9 + ) from C57BL/6 mice at steady state or after in vivo injection of CpG B (1668) complexed to dotap for the indicated time span. ( B ) Dot blots showing expression of BATF in murine BM-derived Flt3L-cultured pDCs at steady state (0h) or after in vitro stimulation of CpG A for the indicated amounts of time. ( C ) Dotblots (upper panel), histogram (lower left) and bar charts (lower right) showing expression of BATF in BM-derived Flt3L-cultured pDCs at steady state (0h) or after in vitro stimulation with CpG B for the indicated amounts of time. Vertical grey line indicates the BATF-median fluorescence intensity (MFI) in resting pDCs. ( D ) Quantitative RT-PCR for the relative expression of Ifnb1 (left) and Isg15 (right) mRNA, in BM-derived Flt3L-cultured, FACS purified pDCs from Ifnar -/- and wild-type ( Ifnar +/+ ) mice. Relative gene expression (mRNA) was analyzed at steady state (untreated) or after 6h stimulation with 1μM CpG or 100 units/ml IFNα4. Data shown are means ± SEM (normalized to Actb ). Data presented in A & B are from one representative sample from the data shown in & B respectively. Data shown are from one representative experiment out of three independent experiments with comparable results. Statistical differences were analyzed using two tailed t test (C) or two-way ANOVA followed by multiple comparisons test using Bonferroni correction (D). Gates were applied in B and C using FMO controls.

    Article Snippet: For the analysis of BATF expression in pDCs the following fluorophore-labelled antibodies were used for staining single cell suspensions in the respective staining panels: for ex vivo BATF analysis: Alexa Fluor 647-BATF (Clone D7C5, Cell Signaling Technology), APC-Cy7-CD11c (Clone N418, BioLegend), PE-CD317/PDCA-1 (Clone eBio927, eBioscience/Thermoscientific), PerCP-Cy5.5-CD3ε (Clone 145-2C11, BD Bioscience), PerCP-Cy5.5-CD19 (Clone 1D3, BD Bioscience), PE-Cy7-CD199/CCR9 (Clone CW-1.2, eBioscience/Thermoscientific); for in vivo BATF analysis: APC-CD11b (Clone M1/70, BD Bioscience), APC-Cy7-TCRβ (Clone H57-597, BioLegend), APC-Cy7-CD19 (Clone 6D5, BioLegend), BV421-SiglecH (Clone 440c, BD Bioscience), BV650-CD317/PDCA-1 (Clone 927, BioLegend), PE-BATF (Clone D7C5, Cell Signaling Technology), PerCP-Cy5.5-CD86 (Clone GL-1, BioLegend), PE-Cy7-CD11c (Clone N418, BioLegend), FITC-CD45R/B220 (Clone RA3-6B2, BD Bioscience).

    Techniques: Expressing, In Vivo, Injection, Derivative Assay, Cell Culture, In Vitro, Fluorescence, Quantitative RT-PCR, Purification, Gene Expression, Two Tailed Test

    ( A ) The mice and liver Oil red O staining in normal diet group (CN) and high-fat diet group (HFD). Bar, 1 cm (left panel) and 100 μm (right panel). ( B ) The protein expression of BATF in liver tissues (n=4). ( C ) The mRNA expression of BATF in liver tissues (n=5). ( D ) Spearman correlation Analysis between TPM of BATF and NAFLD Patients with Different Degrees (n=4–18). ( E ) Triglyceride content (n=5). ( F ) Detection of BATF overexpression in HepG2 (n=2). ( G ) Oil red O staining of HepG2 cells with OA/PA when BATF was overexpressed and ( H ) triglyceride content (n=4). ( I ) Oil red O staining of L02 cells with OA/PA when BATF was overexpressed and ( J ) triglyceride content (n=3). ( K ) Oil red O staining of primary hepatocytes with OA/PA when BATF was overexpressed and ( L ) triglyceride content (n=3). The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 1—source data 1. Effects of BATF on lipid deposition in hepatocytes under high-fat diet.

    Journal: eLife

    Article Title: BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism

    doi: 10.7554/eLife.88521

    Figure Lengend Snippet: ( A ) The mice and liver Oil red O staining in normal diet group (CN) and high-fat diet group (HFD). Bar, 1 cm (left panel) and 100 μm (right panel). ( B ) The protein expression of BATF in liver tissues (n=4). ( C ) The mRNA expression of BATF in liver tissues (n=5). ( D ) Spearman correlation Analysis between TPM of BATF and NAFLD Patients with Different Degrees (n=4–18). ( E ) Triglyceride content (n=5). ( F ) Detection of BATF overexpression in HepG2 (n=2). ( G ) Oil red O staining of HepG2 cells with OA/PA when BATF was overexpressed and ( H ) triglyceride content (n=4). ( I ) Oil red O staining of L02 cells with OA/PA when BATF was overexpressed and ( J ) triglyceride content (n=3). ( K ) Oil red O staining of primary hepatocytes with OA/PA when BATF was overexpressed and ( L ) triglyceride content (n=3). The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 1—source data 1. Effects of BATF on lipid deposition in hepatocytes under high-fat diet.

    Article Snippet: Antibody , BATF (D7C5) (Rabbit monoclonal) , Cell signaling technology , Cat# 8638 , WB (1:1000).

    Techniques: Staining, Expressing, Over Expression

    ( A ) Triglyceride content with OA/PA (n=3). ( B ) BATF mRNA levels. NC, negative control group; siBATF, BATF inhibition group, (n=3). ( C ) Triglyceride content with OA/PA treatment, (n=5). ( D ) Triglyceride content with OA/PA when BATF was overexpressed, (n=3). The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 1—figure supplement 1—source data 1. Effects of BATF on lipid levels in hepatocytes.

    Journal: eLife

    Article Title: BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism

    doi: 10.7554/eLife.88521

    Figure Lengend Snippet: ( A ) Triglyceride content with OA/PA (n=3). ( B ) BATF mRNA levels. NC, negative control group; siBATF, BATF inhibition group, (n=3). ( C ) Triglyceride content with OA/PA treatment, (n=5). ( D ) Triglyceride content with OA/PA when BATF was overexpressed, (n=3). The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 1—figure supplement 1—source data 1. Effects of BATF on lipid levels in hepatocytes.

    Article Snippet: Antibody , BATF (D7C5) (Rabbit monoclonal) , Cell signaling technology , Cat# 8638 , WB (1:1000).

    Techniques: Negative Control, Inhibition

    ( A ) Experimental designs illustration of mice. ( B ) Expression of BATF protein in liver (n=4). ( C ) Densitometric quantification of the blotting. ( D ) Expression of BATF protein in various tissues of HFD-CN mice HBAAV/8-ZsGreen, WB in lane1, 3, 5, 7, 9 and HFD-BATF mice HBAAV2/8-CMV-m-BATF-3×flag-ZsGreen, WB in lane 2, 4, 6, 8, 10. ( E ) Densitometric quantification of the blotting. ( F ) Mice bodyweight (n=8–10). ( G ) Mice fat ratio (n=8–10). ( H ) Mice liver. Bar, 1 cm. ( I ) HE staining of mice liver sections. Bar, 100 μm. ( J ) ( K ) Oil red O staining of mice liver sections and quantitative analysis. Bar, 100 μm (n=3). ( L ) Liver triglyceride levels (n=8–10). ( M ) Liver total Glycerin levels (n=8–10). Figure 2—source data 1. Effects of BATF on hepatic fat deposition in mice.

    Journal: eLife

    Article Title: BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism

    doi: 10.7554/eLife.88521

    Figure Lengend Snippet: ( A ) Experimental designs illustration of mice. ( B ) Expression of BATF protein in liver (n=4). ( C ) Densitometric quantification of the blotting. ( D ) Expression of BATF protein in various tissues of HFD-CN mice HBAAV/8-ZsGreen, WB in lane1, 3, 5, 7, 9 and HFD-BATF mice HBAAV2/8-CMV-m-BATF-3×flag-ZsGreen, WB in lane 2, 4, 6, 8, 10. ( E ) Densitometric quantification of the blotting. ( F ) Mice bodyweight (n=8–10). ( G ) Mice fat ratio (n=8–10). ( H ) Mice liver. Bar, 1 cm. ( I ) HE staining of mice liver sections. Bar, 100 μm. ( J ) ( K ) Oil red O staining of mice liver sections and quantitative analysis. Bar, 100 μm (n=3). ( L ) Liver triglyceride levels (n=8–10). ( M ) Liver total Glycerin levels (n=8–10). Figure 2—source data 1. Effects of BATF on hepatic fat deposition in mice.

    Article Snippet: Antibody , BATF (D7C5) (Rabbit monoclonal) , Cell signaling technology , Cat# 8638 , WB (1:1000).

    Techniques: Expressing, Staining

    ( A ) Average daily feed intake (n=7). ( B ) Liver total cholesterol levels (n=8–10). ( C ) Fasting blood glucose level in mice (n=8–10). ( D ) Liver glucose oxidase activity. ( E ) Glucose tolerance test and ( F ) quantitative analysis (n=5–6). The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 2—figure supplement 1—source data 1. The effect of BATF on metabolic indicators in mice.

    Journal: eLife

    Article Title: BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism

    doi: 10.7554/eLife.88521

    Figure Lengend Snippet: ( A ) Average daily feed intake (n=7). ( B ) Liver total cholesterol levels (n=8–10). ( C ) Fasting blood glucose level in mice (n=8–10). ( D ) Liver glucose oxidase activity. ( E ) Glucose tolerance test and ( F ) quantitative analysis (n=5–6). The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 2—figure supplement 1—source data 1. The effect of BATF on metabolic indicators in mice.

    Article Snippet: Antibody , BATF (D7C5) (Rabbit monoclonal) , Cell signaling technology , Cat# 8638 , WB (1:1000).

    Techniques: Activity Assay

    ( A ) ALT activity in mice liver (n=8). ( B ) AST activity in mice liver (n=7). ( C ) The Fasn , Srebp1 , Gpam , Acc1 mRNA expression level in mice liver (n=6–8). ( D ) The AMPKα1 , Aco , Acox1 , Bcl2 , Cpt1 , Hsl , Acc2 , Atgl mRNA expression level in mice liver (n=6–7). ( E ) SCAD activity in HepG2 cells with OA/PA treatment (n=4). ( F ) ATP content in HepG2 cells with OA/PA treatment (n=4). ( G ) Oxygen consumption rate (OCR). ( H ) Basal respiration, maximal respiration, proton leak and coupling efficiency. The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 3—source data 1. BATF boosts lipid breakdown and energy metabolism in mice livers.

    Journal: eLife

    Article Title: BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism

    doi: 10.7554/eLife.88521

    Figure Lengend Snippet: ( A ) ALT activity in mice liver (n=8). ( B ) AST activity in mice liver (n=7). ( C ) The Fasn , Srebp1 , Gpam , Acc1 mRNA expression level in mice liver (n=6–8). ( D ) The AMPKα1 , Aco , Acox1 , Bcl2 , Cpt1 , Hsl , Acc2 , Atgl mRNA expression level in mice liver (n=6–7). ( E ) SCAD activity in HepG2 cells with OA/PA treatment (n=4). ( F ) ATP content in HepG2 cells with OA/PA treatment (n=4). ( G ) Oxygen consumption rate (OCR). ( H ) Basal respiration, maximal respiration, proton leak and coupling efficiency. The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 3—source data 1. BATF boosts lipid breakdown and energy metabolism in mice livers.

    Article Snippet: Antibody , BATF (D7C5) (Rabbit monoclonal) , Cell signaling technology , Cat# 8638 , WB (1:1000).

    Techniques: Activity Assay, Expressing

    ( A ) CT images of fat axial view. ( B ) eWAT of mice. Bar, 1 cm. ( C ) eWAT weight / bodyweight (n=9–10). ( D ) iWAT of mice. Bar, 1 cm. ( E ) eWAT weight / bodyweight (n=9–10). ( F ) HE staining of eWAT, ( G ) adipocyte diameter and ( H ) cell area. Bar, 200 μm. ( I ) HE staining of iWAT, ( J ) adipocyte diameter and ( K ) cell area. Bar, 200 μm. ( L ) Triglyceride content of undifferentiated 3T3L1 cells (n=5). ( M ) Triglyceride content of differentiated 3T3L1 cells (n=3–4). ( N ) The mRNA expression of IL27 in liver tissues (n=5). The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 4—source data 1. BATF alleviates HFD-induced adipocyte hypertrophy in mice.

    Journal: eLife

    Article Title: BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism

    doi: 10.7554/eLife.88521

    Figure Lengend Snippet: ( A ) CT images of fat axial view. ( B ) eWAT of mice. Bar, 1 cm. ( C ) eWAT weight / bodyweight (n=9–10). ( D ) iWAT of mice. Bar, 1 cm. ( E ) eWAT weight / bodyweight (n=9–10). ( F ) HE staining of eWAT, ( G ) adipocyte diameter and ( H ) cell area. Bar, 200 μm. ( I ) HE staining of iWAT, ( J ) adipocyte diameter and ( K ) cell area. Bar, 200 μm. ( L ) Triglyceride content of undifferentiated 3T3L1 cells (n=5). ( M ) Triglyceride content of differentiated 3T3L1 cells (n=3–4). ( N ) The mRNA expression of IL27 in liver tissues (n=5). The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 4—source data 1. BATF alleviates HFD-induced adipocyte hypertrophy in mice.

    Article Snippet: Antibody , BATF (D7C5) (Rabbit monoclonal) , Cell signaling technology , Cat# 8638 , WB (1:1000).

    Techniques: Staining, Expressing

    ( A ) The mRNA expression of PD1 in liver tissues (n=3). ( B ) The mRNA expression of PD1 in HepG2 cells (n=3). ( C ) Oil red O staining of HepG2 cells, Bar, 20 μm, (n=3). ( D ), ( E ), ( F ) Triglyceride content with OA/PA (n≥3). ( G ) Dual luciferase assay on Hepa1-6 cells cotransfected with firefly luciferase constructs containing the PD1 promoter, Renilla luciferase vector pRL-TK and pcDNA3.1(-) or pcDNA3.1(-)-BATF, (n≥3). ( H ) The Mechanism diagram of BATF alleviates hepatocyte lipid accumulation by PD1. The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 5—source data 1. BATF alleviates hepatocyte lipid accumulation by inhibiting PD1.

    Journal: eLife

    Article Title: BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism

    doi: 10.7554/eLife.88521

    Figure Lengend Snippet: ( A ) The mRNA expression of PD1 in liver tissues (n=3). ( B ) The mRNA expression of PD1 in HepG2 cells (n=3). ( C ) Oil red O staining of HepG2 cells, Bar, 20 μm, (n=3). ( D ), ( E ), ( F ) Triglyceride content with OA/PA (n≥3). ( G ) Dual luciferase assay on Hepa1-6 cells cotransfected with firefly luciferase constructs containing the PD1 promoter, Renilla luciferase vector pRL-TK and pcDNA3.1(-) or pcDNA3.1(-)-BATF, (n≥3). ( H ) The Mechanism diagram of BATF alleviates hepatocyte lipid accumulation by PD1. The data are expressed as mean ± SD. *p<0.05, **p<0.01. Figure 5—source data 1. BATF alleviates hepatocyte lipid accumulation by inhibiting PD1.

    Article Snippet: Antibody , BATF (D7C5) (Rabbit monoclonal) , Cell signaling technology , Cat# 8638 , WB (1:1000).

    Techniques: Expressing, Staining, Luciferase, Construct, Plasmid Preparation

    Journal: eLife

    Article Title: BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism

    doi: 10.7554/eLife.88521

    Figure Lengend Snippet:

    Article Snippet: Antibody , BATF (D7C5) (Rabbit monoclonal) , Cell signaling technology , Cat# 8638 , WB (1:1000).

    Techniques: Mouse Assay, Transfection, Construct, Virus, Isolation, Infection, Recombinant, Cell Culture, Retroviral, Transduction, Plasmid Preparation, Luciferase, Activity Assay, Sequencing, Synthesized, Reverse Transcription, Cloning, Reporter Gene Assay, Software, Injection, Control

    Journal: Cell Reports Medicine

    Article Title: CD8 + T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

    doi: 10.1016/j.xcrm.2022.100878

    Figure Lengend Snippet:

    Article Snippet: BATF was detected in western blots using anti-BATF clone D7C5 (Cell Signaling Technology, Danvers, MA).

    Techniques: Control, Recombinant, Cell Stimulation, Staining, Cell Isolation, cDNA Synthesis, Expressing, CRISPR, Negative Control, In Situ Hybridization, Software